Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Net Income towards Common Stockholders (2016 - 2026)

MedWellAI has reported Net Income towards Common Stockholders over the past 12 years, most recently at -$287519.0 for Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 57.34% to -$287519.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.7 million through Dec 2025, up 34.36% year-over-year, with the annual reading at -$3.6 million for FY2025, 69.97% up from the prior year.
  • Net Income towards Common Stockholders was -$287519.0 for Q4 2025 at MedWellAI, up from -$651878.0 in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $1.2 million in Q3 2021 and troughed at -$22.3 million in Q2 2023.
  • The 5-year median for Net Income towards Common Stockholders is -$1.1 million (2022), against an average of -$3.4 million.
  • The largest YoY upside for Net Income towards Common Stockholders was 412.76% in 2021 against a maximum downside of 3630.14% in 2021.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$650774.0 in 2021, then tumbled by 114.5% to -$1.4 million in 2022, then skyrocketed by 59.35% to -$567360.0 in 2023, then decreased by 18.78% to -$673911.0 in 2024, then soared by 57.34% to -$287519.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Net Income towards Common Stockholders are -$287519.0 (Q4 2025), -$651878.0 (Q3 2025), and -$1.1 million (Q2 2025).